Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis.
Saved in:
| Title: | Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis. |
|---|---|
| Authors: | Michaelis T; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA., Lindestam Arlehamn CS; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA.; Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Johansson E; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA.; Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, Sweden., Frazier A; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA., Williams GP; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA., Berry JD; Sean M. Healey and AMG Center for ALS, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Cudkowicz M; Sean M. Healey and AMG Center for ALS, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Goyal NA; Department of Neurology, University of California, Irvine, Irvine, CA, USA., Fournier C; Department of Neurology, Emory University, Atlanta, GA, USA., Snyder A; Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kwan JY; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Crook J; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Phillips EJ; Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.; Vanderbilt University School of Medicine, Nashville, TN, USA., Mallal SA; Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.; Vanderbilt University School of Medicine, Nashville, TN, USA., Ravits J; Department of Neurosciences, School of Medicine, University of California, San Diego, La Jolla, CA, USA., Marder KS; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA., Sidney J; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA., Sulzer D; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA. ds43@cumc.columbia.edu.; Departments of Psychiatry, Neurology and Pharmacology, Columbia University, New York, NY, USA. ds43@cumc.columbia.edu., Sette A; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA. alex@lji.org.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, USA. alex@lji.org. |
| Source: | Nature [Nature] 2025 Nov; Vol. 647 (8091), pp. 970-978. Date of Electronic Publication: 2025 Oct 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
